STG Wealth Serve Private Limited has acquired a significant stake in Callista Industries Ltd through a preferential allotment of equity shares. The acquirer obtained 5,00,000 shares on June 24, 2026, representing an 8.63% holding in the company's total share capital and 1.67% of the total diluted share capital. The shares carry a face value of Rs. 10 each and were allotted on a fully paid-up basis.

The disclosure was submitted to BSE Limited by Neeraj Kumar Chopra, Director of STG Wealth Serve Private Limited, under Regulation 29 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirmed that the acquirer does not belong to the promoter or promoter group of the target company.

Acquisition Details

The transaction details outline the changes in shareholding and capital structure following the allotment. The equity shares were acquired solely through preferential allotment, with no other instruments such as warrants or convertible securities involved in this specific transaction.

Capital Structure Impact

The allotment resulted in a revision of Callista Industries Ltd's equity share capital. Prior to the acquisition, the total voting capital stood at Rs. 4,69,65,880. Post-allotment, this figure increased to Rs. 5,79,65,880. The total diluted share capital of the company after the acquisition is reported at Rs. 29,94,65,880.

The filing confirms that STG Wealth Serve Private Limited held no shares in Callista Industries Ltd prior to this transaction. The acquisition was executed entirely on a fully paid-up basis, and since the securities allotted were equity shares, no conversion, redemption, or exercise terms were applicable.

Callista Industries Limited has secured in-principle approval from BSE Limited to raise capital through a preferential issue of convertible warrants and equity shares. The approval allows the company to issue 2,12,50,000 convertible warrants and 56,50,000 equity shares at a price of ₹10 each to the Promoter Group and Non-Promoter Category. This capital infusion is intended to support the company's growth objectives following necessary board and shareholder approvals.

BSE Limited granted the approval via its letter bearing reference number LOD/PREF/PB/FIP/411/2026-27 dated June 19, 2026. The regulatory nod is valid for a period of 15 days from the date of issuance. The company must ensure that the issue and allotment of securities strictly comply with the provisions of the Companies Act, 2013, and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

The exchange has advised the company to strengthen internal controls to monitor trades executed by the proposed allottees. Specifically, Callista Industries must obtain an undertaking from allottees confirming they will not engage in intra-day trading or sell the company's scrip until the allotment date. The responsibility for verifying this compliance and ensuring adherence to Regulation 167(6) of the SEBI ICDR Regulations rests solely with the issuer company.

Following the allotment of securities, the company is required to submit a listing application without delay, along with the applicable fees, in terms of Regulation 14 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Failure to make the listing application within twenty days from the date of allotment may result in penalties as specified in relevant SEBI circulars.

The following table outlines the details of the securities approved for issuance: